Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma.

Molecular Oncology
Thomas UrupHans Skovgaard Poulsen

Abstract

Patients with recurrent glioblastoma achieving response to bevacizumab combined with chemotherapy have clinical improvement and prolonged survival. High gene expression of angiotensinogen (AGT) is associated with a poor bevacizumab response. Because AGT expression is epigenetically regulated, we aimed to investigate whether AGT promoter methylation in tumor tissue predicts response to bevacizumab combination therapy in patients with recurrent glioblastoma. The study included 159 patients with recurrent glioblastoma, treated with bevacizumab combination treatment (training cohort, n = 77; validation cohort, n = 82). All patients could be evaluated for treatment response and biomarkers. DNA methylation of 4 CpG sites in the AGT promoter was measured using pyrosequencing. A model for nonresponse was established using logistic regression analysis. In the training cohort, lower methylation of each of the four CpG sites in the AGT promoter was significantly associated with nonresponse (all P < 0.05). Moreover, the mean methylation level of all four CpG sites was associated with an increased likelihood of not achieving response to bevacizumab combination therapy (twofold decrease: odds ratio = 3.01; 95% confidence interval: 1.41-6.44;...Continue Reading

References

Mar 5, 2004·British Journal of Cancer·L Juillerat-JeanneretJ-M Gasc
Oct 23, 2004·Circulation Research·Ken KazamaCostantino Iadecola
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 4, 2006·Physiological Reviews·Martin PaulReinhold Kreutz
May 4, 2007·American Journal of Physiology. Cell Physiology·Sudhir JainAshok Kumar
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Dec 25, 2009·Nature·Maria Stella CarroAntonio Iavarone
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Jul 12, 2011·Physiological Reviews·Shom GoelRakesh K Jain
Oct 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Triantafyllos Stylianopoulos, Rakesh K Jain
Nov 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Tracy T BatchelorRakesh K Jain
Jan 13, 2015·Journal of Neurology·Johnny DuerinckAnne Rogiers
Oct 23, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raymond Y HuangPatrick Y Wen
Nov 16, 2017·The New England Journal of Medicine·Wolfgang WickMartin J van den Bent
Jan 14, 2018·Journal of Neuro-oncology·J N JakobsenH S Poulsen
Feb 8, 2019·Cancer Investigation·Maria Dinche JohansenHans Skovgaard Poulsen

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
surgical resection

Software Mentioned

pyromark q 24
R
spss
sas

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Comprehensive Cancer Network : JNCCN
L Burt Nabors
Future Oncology
David PiccioniTimothy Cloughesy
The Oncologist
Filis Kazazi-HyseniJan H M Schellens
© 2021 Meta ULC. All rights reserved